Abstract: An electric device according to the present invention includes a main body portion of the electric device that is designed to be connected to a battery park. A connecting portion for connecting the battery pack is formed to the main body portion of the electric device. A terminal supporting plate having at leased a pair of terminals and for connecting terminals of the battery pack is fixed to the connecting portion. The terminals and are arranged on a front surface side of the terminal supporting plate that is exposed from the connecting portion. An electric material component is arranged on a rear surface side of the terminal supporting plate.

Abstract: A battery housing portion S includes regulating members 30 adapted to fit grooves of a battery pack having a T-shape cross section, so that the battery pack can be housed in the battery housing portion S in the state that the both regulating members 30 fit the grooves. The regulating members 30 regulate housing orientation of the battery pack 20, so that misjudgment about orientation of the battery pack 20 is prevented. In addition, if the orientation has been misjudged, an operator can notice such misjudgment immediately, thereby improving the operability during mounting the battery pack 20.

Abstract: A charger is adopted to charge a first-type battery pack and a second-type battery pack, each type of battery packs having an insertion portion whose shapes are different. The charger is provided with a housing having a battery pack socket for inserting the battery packs. The battery pack socket has a shape that allows the insertion portion of the first-type battery pack and the insertion portion of the second-type battery pack to be inserted thereto selectively in a prescribed attitude. A pair of output terminals that output charging power is disposed within the battery pack socket. The pair of output terminals is electrically connected to the first-type battery pack when the insertion portion of the first-type battery pack is inserted into the battery pack socket in the prescribed attitude.

Abstract: An apparatus for designing a layout includes an arranging unit that arranges, on a large-scale-integrated chip, a cell in which a signal line segment that is not connected to a terminal is formed; a wiring unit that wires a signal line to an arbitrary wiring layer of the large-scale-integrated chip; and a connecting unit that connects the signal line segment with the signal line.

Abstract: An apparatus for designing a layout includes an arranging unit that arranges, on a large-scale-integrated chip, a cell in which a signal line segment that is not connected to a terminal is formed; a wiring unit that wires a signal line to an arbitrary wiring layer of the large-scale-integrated chip; and a connecting unit that connects the signal line segment with the signal line.

Abstract: Glycopeptide antibiotics PA-45052 which are produced by Nocardia orientalis PA-45052, show potent activity against gram-positive bacteria, especially against methicillin-resistant bacteria, and stimulate growth of animals.

Abstract: An anti-mycoplasma agent comprising tropolone, its derivatives, represented by the formula: ##STR1## (wherein R.sub.1 is hydroxy, aliphatic acyloxy, arylacyloxy, arysulfonyloxy, carboxyalkyloxy or its ester, benzoylalkyloxy, alkenyloxy, 1,3-dihydro-3-oxo-1-isobenzofuranyloxy, (2-oxo-5-methyl-1,3-dioxol-4-yl)methyloxy or thiocyanato and R.sub.2 is hydrogen, halogen, hydroxy, alkyl or alkoxy) and their salts as an active ingredient, which has potent activity especially against tylosin-resistant mycoplasma both in vitro and in vivo and is effectively used in treating the diseases caused thereby.

Abstract: The compounds of the formula: ##STR1## wherein R is ##STR2## or H, wherein X is NH.sub.2 and Y is CH.sub.3 ; or X is OH and Y is H, and their pharmaceutically acceptable salts. The compounds have a potent activity against gram-positive bacteria, especially, methicillin-resistant bacteria.

Abstract: The whole DNA sequence coding for flagellin of E. coli (hag gene) cloned in phage .lambda. was determined. The hag gene is introduced into pBR322 and the region of the hag gene concerning the antigencity of flagella is lacked, into which linkers are inserted. Where the vector in which foreign DNA is inserted in the linker is introduced in E. coli forming no flagella, the E. coli can form flagella and possesses motility. The flagella comprises flagellin fused with foreign peptide encoded by the foreign DNA. Namely, the foreign peptide is excreted outside of bacteria. This system can be utilized in determination of epitope and preparation of antigen as well as excretion of peptide.

Abstract: Antibiotics PA-41746-A.sub.2, PA-41746-E and PA-41746-F produced by fermentation of Streptomyces pluracidomyceticus on a conventional culture medium, having .beta.-lactamase inhibitory activities and excellent antimicrobial activities, and useful as drugs for treatment of infections in humans or animals, or as disinfectants.

Abstract: Antibiotics DO-248-A and DO-248-B of the following Formula I: ##STR1## wherein R is ethyl or isopropyl, have antibacterial activity against acid-fast bacteria. DO-248-A, DO-248-B, or their pharmaceutically acceptable salts are, as an active ingredient of anti-fast-acid drugs, orally or parenterally administered to human beings or animal. DO-248-A and DO-248-B are prepared by incubating an antibiotic DO-248-A- and/or DO-248-B-producing microorganism belonging to genus Streptoverticillium in a medium and recovering antibiotic DO-248-A and/or DO-248-B from the culture broth.

Abstract: An inexpensive or economical ignition device which is capable of advancing the ignition timing in proportion to an increase in the engine speed when it stays within a preset range and obtaining constant minimum and maximum ignition angle characteristics when the engine speed is below and above the preset range, respectively, so that the ignition device may be operate in conformity with the output characteristic of an engine. A driving power source for the controller of the ignition device can be provided independently of the pulser coil, thereby to greatly stabilize the ignition characteristic in the low engine speed region.

Abstract: A new antibiotic having .beta.-lactamase inhibitory activity, PA-39504-X.sub.1 of the formula: ##STR1## being useful as a medicament and a veterinary drug for inhibiting the growth of gram-positive and gram-negative pathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces argenteolus PA-39504 or Streptomyces tokunonensis PA-31088 in a suitable medium and recovering PA-39504-X.sub.1 from the cultured broth.

Abstract: New antibiotics having .beta.-lactamase inhibitory activity, PA-41746-B and C of the formula ##STR1## wherein R is carboxymethylsulfinyl (PA-41746-B) or formylsulfinyl (PA-41746-C) and the pharmaceutically acceptable salts being useful as a medicament, a veterinary drug and a disinfectant for inhibiting the growth of gram-positive and gram-negative pathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces pluracidomyceticus in a suitable medium and isolating PA-41746-B and/or PA-41746-C from the culture broth.

Abstract: A new antibiotic having .beta.-lactamase inhibitory activity, PA-39504-X.sub.3 of the formula: ##STR1## and the pharmaceutically acceptable slats being useful as a drug, a animal drug and a disinfectant for inhibiting the growth of gram-positive and gram-negative pathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces argenteolus PA-39504 or Streptomyces tokunonensis PA-31088 in a suitable medium and isolating PA-39504-X.sub.3 from the cultured broth.

Abstract: A new process for preparing thienamycin, a known antibiotic useful as a medicament and veterinary drug, characterized by cultivating Streptomyces penemifaciens sp. nov. in a suitable medium and recovering thienamycin from the fermentation broth.

Abstract: A process for producing 6-aminopenicillanic acid and 6-aminopenicillanic acid S-oxide by means of enzymes produced by microbes belonging to Arthrobacter genus, especially Arthrobacter cremorum and Arthrobacter flagellum.

Abstract: A new antibiotic having .beta.-lactamase inhibitory activity, PA-39504-X.sub.1 of the formula: ##STR1## being useful as a medicament and a veterinary drug for inhibiting the growth of gram-positive and gram-negative pathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces argenteolus PA-39504 or Streptomyces tokunonensis PA-31088 in a suitable medium and recovering PA-39504-X.sub.1 from the cultured broth.